Weekly Roundup: Catalent acquires Bristol-Myers Squibb’s production site, KD Pharma refinances US$166m debt facilities

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

03 Jul 2020 --- This week in nutrition news, Evolva set itself up to strengthen its resveratrol products’ position in the nutrition sector with an agreement to issue and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

30 Jun 2020 --- The nutrition industry is fighting back against allegations that probiotics lack industry regulation and sport insufficient scientific consensus over their health... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

26 Jun 2020 --- World Microbiome Day, celebrated every June 27, aims to raise the profile of microbiome research around the world. This year’s theme “Diversity”... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Jun 2020 --- NattoPharma is partnering with KD Nutra – a KD Pharma Group company – to develop a new ingredient for cardiovascular (CV) health. The product will... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Jun 2020 --- Functional supplements are attracting busy consumers across generational age groups, who all seek to live healthier and stress-free lives despite differing... Read More

trans